Adakveo is a humanized anti-P-selectin monoclonal antibody indicated to reduce the incidence of vaso-occlusive crises in sickle cell disease in patients ≥16 years of age.
Active ingredient: crizanlizumab
Holding temperature: 2-8 degrees
Prescription medicine.